John Overdeck Two Sigma Investments

John Overdeck's Q1 2022 Portfolio in Review

As of Q1 2022, John Overdeck held 4,846 positions worth $33.9B, down 28% from $46.8B the previous quarter. Its ten largest holdings account for 7.2% of the portfolio.

John Overdeck withdrew a net $11.3B in Q1 2022, closing 2,304 positions and reducing 976 holdings. Its most notable exit was Pfizer, an estimated $271M position sold in full.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, John Overdeck opened a new position in Cisco worth $223M.

• John Overdeck's largest Q1 2022 buy was Cisco: 4,001,362 shares worth $223M.
• John Overdeck added most to JPMorgan Chase in Q1 2022, an estimated $212M increase.
• John Overdeck's biggest Q1 2022 reduction was Coca-Cola, cutting an estimated $225M.
• John Overdeck fully exited Pfizer in Q1 2022, selling an estimated $271M.
• John Overdeck's ten largest holdings make up 7.2% of its $33.9B portfolio in Q1 2022.
• John Overdeck opened 656 new positions and closed 2,304 in Q1 2022.
• John Overdeck's portfolio value fell 28% quarter-over-quarter to $33.9B.

Based on Two Sigma Investments's 13F filing for Q1 2022, filed 16 May 2022.